CANNABICS PHARMACEUTICALS, INC (CNBX)

CNBX
Symbol Name Last Trade Price Change Change (%) Volume




Revenue 1 year Target Price 52 week Range Stock Exchange Last Trade Size

Cannabics Pharmaceuticals Inc., formerly American Mining Company, is a biotechnology pharmaceutical company. The Company is engaged in pharmaceutical development. The Company is focused on development and licensing of cannabinoid-based treatments and therapies. It develops and markets various therapies and biotechnological tools aimed at providing relief from ailments that respond to active ingredients sourced from the cannabis plant. These tools include delivery systems for cannabinoids, personalized medicine therapies and procedures based on cannabis originated compounds, and bioinformatics tools. The Company’s flagship product is CANNABICS SR. CANNABICS SR is a technology for a long acting oil capsule that provides administration of cannabis. CANNABICS SR is composed solely from food grade materials and delivers effects for over 10 to 12 hours. The delivery method enables a once per day dosing regimen of medical cannabis to patients. It has not generated revenues.

Breaking News Arrows

Breaking News

  • Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol ResearchDecember 5, 2019Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that Dr. Yaakov Waksman is to join the company as Head of Cannabidiol Research.
  • Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer TherapiesOctober 16, 2019Data Demonstrated Cannabics' SR capsules with 5 mg dosage seems to be appropriate for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients under active treatment. TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the final results of its pilot study to test the efficacy of Cannabics' Dosage-Controlled capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients have been published on the Journal of Integrative Cancer Therapies.
  • Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of DirectorsOctober 7, 2019TEL AVIV, Israel and BETHESDA, Maryland, Oct. 7, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX), a leader in personalized cannabinoid based cancer medicine, today announced that it has appointed the Company's Founder as a new Director and Member of its Board. Itamar Borochov, 62, is an environmentalist with vast experience as an entrepreneur in the medical cannabis field, with broad experience in management and finance in medical cannabis companies which operate in regulated markets. Mr. Borochov was the original Founder of Cannabics Pharmaceuticals Inc.
  • Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MASeptember 12, 2019TEL AVIV, Israel and BETHESDA, Maryland, Sept. 12, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX), a leader in personalized cannabis based cancer medicine, today announced that its Scientific Director, Dr. Ilan Hochman, is scheduled to present research data from cannabinoid tests on live cancer biopsies at the 2nd  International Cannabinoid Derived Pharmaceuticals Summit, to be held in Boston, MA, on September 10-12, 2019. The company has been focusing on developing solutions for bringing cannabis based solutions into the mainstream of cancer treatments together with existing therapeutic approaches.
  • 'Algorithms Manage Everything': One Israeli Company's Mission To Make Marijuana Growing EffortlessJuly 17, 2019Cannabis cultivation is a meticulous process that involves more than just planting a seed or a clone and watering it regularly. Luckily, there are solutions that make growing weed easier, even in the comfort of one’s home. One of these solutions is Seedo, a special pod that takes care of the entire growing process and can be controlled through an app on a smartphone.